LOGIN  |  REGISTER
Chimerix

Recent Insider Transactions - LENZ Therapeutics (NASDAQ: LENZ)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ LENZ LENZ Therapeutics
Versant Venture Capital VI, L.P. / 10 percent owner
06/27/2025
Sell
$30.47
200,000
$6.093M
1.77M
NASDAQ LENZ LENZ Therapeutics
Versant Venture Capital VI, L.P. / 10 percent owner
06/20/2025
Sell
$30.25
133,924
$4.051M
1.97M
NASDAQ LENZ LENZ Therapeutics
Versant Venture Capital VI, L.P. / 10 percent owner
06/18/2025
Sell
$29.95
100,000
$2.995M
1.15M
NASDAQ LENZ LENZ Therapeutics
Versant Venture Capital VI, L.P. / 10 percent owner
06/20/2025
Sell
$30.35
100,877
$3.062M
1.05M
NASDAQ LENZ LENZ Therapeutics
Versant Venture Capital VI, L.P. / 10 percent owner
06/10/2025
Sell
$29.00
350,000
$10.150M
1.25M
NASDAQ LENZ LENZ Therapeutics
RA CAPITAL MANAGEMENT, L.P. / director, 10 percent owner:
06/11/2025
Buy
$30.00
13,500
$405K
13,500
NASDAQ LENZ LENZ Therapeutics
George Jeffrey P. / director
06/11/2025
Buy
$30.00
13,500
$405K
13,500
NASDAQ LENZ LENZ Therapeutics
Drapkin Kimberlee C / director
06/11/2025
Buy
$30.00
13,500
$405K
13,500
NASDAQ LENZ LENZ Therapeutics
Guerard Frederic / director
06/11/2025
Buy
$30.00
13,500
$405K
13,500
NASDAQ LENZ LENZ Therapeutics
Thunen Shelley B / director
06/11/2025
Buy
$30.00
13,500
$405K
13,500
NASDAQ LENZ LENZ Therapeutics
MCCOLLUM JAMES W / director
06/11/2025
Buy
$30.00
13,500
$405K
13,500
NASDAQ LENZ LENZ Therapeutics
Scheiner Zachary / director
06/11/2025
Buy
$30.00
13,500
$405K
13,500